E.g., 12/17/2018
E.g., 12/17/2018
Title Category Credit Event date Price
CPS Surgical Management of Kidney Stones (2016)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Problem Solving (CPS) Protocols guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. The purpose of this Guideline is to provide a clinical framework for the surgical management of patients with kidney and/or ureteral stones.
Doppler and Advanced Techniques in Urologic Ultrasound Video (2017)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$125.00 The advanced urologic ultrasound course is designed for participants who have a basic understanding of the physics of ultrasound and some experience with clinical scanning.  This course teaches the physics of Doppler ultrasound and how to use physical principles to improve image quality and understand ultrasound artifacts.  The course is important for those urologists seeking to improve their ultrasound expertise in the operating room and in the office.  
Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer (2017)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 The AUA developed the Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer initiative to include multiple educational interventions to improve the urologist, medical oncologist, and other healthcare provider's ability to care for patients with bladder cancer. These activities are designed to increase the clinician's competence in the application of new and emerging treatment options, including the sequencing and associated side effects of those options.
Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines and Beyond Webcast (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 There is a growing need for urologists to be able to effectively manage castration-resistant prostate cancer (CRPC).  The AUA recently released its 2017 report on the educational needs of urologists in the area of CRPC. These findings show strong support for the AUA to influence key stakeholders in urology residency programs in order to increase the amount of exposure residents receive in this area.
Emerging Treatment Options for Non-Metastatic CRPC Podcast (2018)
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary Emerging Treatment Options for Non-Metastatic CRPC Podcast (2018).
Evidence-Based Clinical Management of Advanced and Castration-Resistant Prostate Cancer - Phoenix (2018)
  • 5.25 AMA PRA Category 1 Credit™
  • 5.25 Non-Physician Participation
11/27/2018 $0.00 Presented by the AUA in partnership with the Society of Urologic Oncology (SUO).
Female Sexual Dysfunction for APPs (2017)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
$40.00 Member only benefit! The prevalence of Female Sexual Dysfunction (FSD) a disease encompassing sexual desire and arousal disorders, orgasmic disorders, and sexual pain disorders, is a complex and important clinical issue. In the National Health and Social Life Survey, 43% of women reported some degree of sexual difficulty. There is a disparity in the treatment of sexual dysfunction between women and men that is now correcting.
Fundamentals in Urology (2019) 06/07/2019 $820.00 Back by Popular Demand!New Location for 2019: Indianapolis Marriott Downtown, Indianapolis, INThe Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms.
Fundamentals in Urology Webcast (2018)
  • 33.50 AMA PRA Category 1 Credit™
  • 33.50 Non-Physician Participation
$805.00 Specifically designed for anyone unable to get away from the office to attend the Live Course - the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials. 
Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on:Discussing the evolving landscape of adjuvant therapy for the treatment of kidney cancer and debating the elements of disagreement in this area.Differentiating the roles of urologist and medical oncologist in the care of patients with kidney cancer.Appreciating the patient’s journey through RCC and identifying their needs as it relates to the coordination of care between the urologists and medical oncologist.
Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on:Discussing the evolving landscape of adjuvant therapy for the treatment of kidney cancer and debating the elements of disagreement in this area.Differentiating the roles of urologist and medical oncologist in the care of patients with kidney cancer.Appreciating the patient’s journey through RCC and identifying their needs as it relates to the coordination of care between the urologists and medical oncologists.
Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on:Discussing the evolving landscape of adjuvant therapy for the treatment of kidney cancer and debating the elements of disagreement in this area.Differentiating the roles of urologist and medical oncologist in the care of patients with kidney cancer.Appreciating the patient’s journey through RCC and identifying their needs as it relates to the coordination of care between the urologists and medical oncologist.
Immuno-Oncology: A Focus on Bladder Cancer Webcast (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary.
Immuno-Oncology: A Focus on Kidney Cancer Webcast (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary.
Immuno-Oncology: A Focus on Prostate Cancer Webcast (2018)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
$0.00 To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. This is the fourth in a series of 4 webinars.

Pages